49296-7 |
Protein pattern |
Imp |
Ser/Plas |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49296-7 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Prot Pattern SerPl Elph-Imp |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49297-5 |
Protein pattern |
Imp |
Ser/Plas |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49297-5 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Prot Pattern SerPl IFE-Imp |
|
|
|
N |
|
Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49298-3 |
Protein pattern |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Protein Fractions [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49298-3 |
|
|
|
|
Observation |
|
|
|
0 |
Prot Pattern SerPl-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49299-1 |
Protein pattern |
Imp |
Urine |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Protein Fractions [Interpretation] in Urine by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49299-1 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Prot Pattern Ur Elph-Imp |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Narrative; Nephrology; PEUR; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Renal; Report; UA; UPEP; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
493-7 |
Temocillin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Temocillin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
493-7 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Temocillin Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Nagaban; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Temopen |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4930-4 |
HLA-DPw6 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw6 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4930-4 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw6 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
49300-7 |
Protein pattern |
Imp |
Urine |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Protein Fractions [Interpretation] in Urine by Immunofixation Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49300-7 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Prot Pattern Ur IFE-Imp |
|
|
|
N |
|
Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Narrative; Nephrology; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Renal; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49301-5 |
Protein pattern |
Imp |
Urine |
24H |
Nar |
Electrophoresis |
|
ACTIVE |
Protein Fractions [Interpretation] in 24 hour Urine by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49301-5 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Prot Pattern 24h Ur Elph-Imp |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Narrative; Nephrology; PEUR; PR; Prot; Prot Pattern; Protein fractions; Renal; Report; UA; UPEP; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49302-3 |
Protein pattern |
Imp |
XXX |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Protein Fractions [Interpretation] in Specimen by Immunofixation Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49302-3 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Prot Pattern Spec IFE-Imp |
|
|
|
N |
|
Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Narrative; Other; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; Spec; To be specified in another part of the message; Unspecified |
2.69 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49303-1 |
Amino acid pattern |
Imp |
CSF |
Pt |
Nar |
|
|
ACTIVE |
Amino acid pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49303-1 |
|
|
|
|
Observation |
|
|
|
0 |
Amino acid Pat CSF-Imp |
|
|
|
N |
|
Acd; Acids; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Added 'pattern' to Component to harmonize with existing amino acids pattern interpretation terms that are conceptually the same. |
0 |
49304-9 |
Uranium dose assessment |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Uranium dose assessment [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
49304-9 |
|
|
|
|
Observation |
|
|
|
0 |
Uranium Dose Assessment Ur-Imp |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; U; UA; UR; Urn |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49305-6 |
Spermatozoa evaluation.cervical mucus penetration test |
Imp |
Semen |
Pt |
Nar |
|
|
ACTIVE |
Cervical Mucus Penetration Test [Interpretation] in Semen Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
FERT |
|
49305-6 |
|
|
|
|
Observation |
|
|
|
0 |
CMSPT Smn-Imp |
|
|
|
N |
|
Assessment; Cerv; CMSPT; Cvx Mucus; Ejaculate; Eval; FERTILITY TESTING; Genitourinary; GU; H&P; History and physical; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Mucous; Mucous Threads; Narrative; Point in time; Post coital test; Random; Report; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49306-4 |
Spermatozoa evaluation.hamster ova penetration test |
Imp |
Semen |
Pt |
Nar |
|
|
ACTIVE |
Hamster Ova Penetration Test [Interpretation] in Semen Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
FERT |
|
49306-4 |
|
|
|
|
Observation |
|
|
|
0 |
SPA Smn-Imp |
|
|
|
N |
|
Assessment; Ejaculate; Eval; FERTILITY TESTING; Genitourinary; GU; H&P; Hamster Zona-Free Ovum Test; History and physical; Humster Test; HZFO Test; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Ovum; Point in time; Random; Report; Sem; Seminal fluid; Smn; SMPLS; SPA; Sperm; Sperm penetration assay; URO; Urology |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49307-2 |
Myocardium Ab pattern |
Imp |
Ser |
Pt |
Nar |
|
|
ACTIVE |
Myocardium Ab pattern [Interpretation] in Serum Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
49307-2 |
|
|
|
|
Observation |
|
|
|
0 |
Myocardium Ab pattern Ser-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Antimyocardial; Antisarcolemma; Autoantibodies; Autoantibody; Cardio; Cardiology; Heart; Heart Disease; Impression; Impression/interpretation of study; Impressions; Intermyofibrillar Antibodies; Interp; Interpretation; Myocardial; Narrative; Point in time; Random; Report; Serology; Serum; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49308-0 |
Neutrophil cytoplasmic Ab pattern |
Imp |
Ser |
Pt |
Nar |
IF |
|
ACTIVE |
Neutrophil cytoplasmic Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
49308-0 |
|
IF |
|
|
Observation |
|
|
|
0 |
ANCA Ab pattern Ser IF-Imp |
|
|
|
N |
|
ABS; Aby; ACIF; ACNA; ACPA; ANCA; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA Pat; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Neut; Neutr; Neutrophils; PMN; PNM; Point in time; Random; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Vasculitis |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49309-8 |
Nuclear Ab pattern |
Imp |
Body fld |
Pt |
Nar |
IF |
|
ACTIVE |
Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
49309-8 |
|
IF |
|
|
Observation |
|
|
|
0 |
ANA Pat Fld IF-Imp |
|
|
|
N |
|
ABS; Aby; ACIF; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; FA; FANA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Narrative; Nuc; Point in time; Random; Report; Serology; Time Resolved Fluorescence; TRF |
2.22 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4931-2 |
HLA-DPw6 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw6 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4931-2 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw6 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
49310-6 |
Nuclear Ab pattern |
Imp |
Ser |
Pt |
Nar |
|
|
ACTIVE |
Nuclear Ab pattern [Interpretation] in Serum Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
49310-6 |
|
|
|
|
Observation |
|
|
|
0 |
ANA Pat Ser-Imp |
|
|
|
N |
|
ABS; Aby; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Narrative; Nuc; Point in time; Random; Report; Serology; Serum; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49311-4 |
Nuclear Ab pattern |
Imp |
Ser |
Pt |
Nar |
IF |
|
ACTIVE |
Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
49311-4 |
|
IF |
|
|
Observation |
|
|
|
0 |
ANA Pat Ser IF-Imp |
|
|
|
N |
|
ABS; Aby; ACIF; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Narrative; Nuc; Point in time; Random; Report; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49312-2 |
Acute leukemia markers |
Imp |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Acute leukemia markers [Interpretation] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
49312-2 |
|
|
|
|
Observation |
|
|
|
0 |
Acute leukemia markers Spec-Imp |
|
|
|
N |
|
CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49313-0 |
Chronic leukemia markers |
Imp |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Chronic leukemia markers [Interpretation] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
49313-0 |
|
|
|
|
Observation |
|
|
|
0 |
Chronic Leukemia Markers Spec-Imp |
|
|
|
N |
|
CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49314-8 |
Immunodeficiency markers |
Imp |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Immunodeficiency markers [Interpretation] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
49314-8 |
|
|
|
|
Observation |
|
|
|
0 |
Immunodeficiency Markers Spec-Imp |
|
|
|
N |
|
CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49315-5 |
Hemolytic disease of newborn screen |
Imp |
Bld |
Pt |
Nar |
|
|
ACTIVE |
Hemolytic disease of newborn screen [Interpretation] in Blood Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
49315-5 |
|
|
|
|
Observation |
|
|
|
0 |
HDNB Scn Bld-Imp |
|
|
|
N |
|
Blood; BLOOD BANK; Dis; Diseases; Dz; HDNB Scn; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; New born; Point in time; Random; Report; Scn; Scr; Scrn; WB; Whole blood |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49316-3 |
Hemoglobin pattern |
Imp |
Bld |
Pt |
Nom |
Electrophoresis |
|
ACTIVE |
Hemoglobin pattern [Interpretation] in Blood by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
49316-3 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Hgb Fract Bld Elph-Imp |
|
|
|
N |
|
Blood; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
49317-1 |
Hemoglobin pattern |
Imp |
Bld |
Pt |
Nar |
|
|
ACTIVE |
Hemoglobin pattern [Interpretation] in Blood Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
49317-1 |
|
|
|
|
Observation |
|
|
|
0 |
Hgb Fract Bld-Imp |
|
|
|
N |
|
Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; WB; Whole blood |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |